A New Perspective in Tumor Therapy: Targeting M2-Type Tumor-Associated Macrophages
Technology in Cancer Research & Treatment · 2026-05 · 25
DOI: 10.1177/15330338261448345 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 06.05.2026. Verfasst von Qiang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Neoplasms, Macrophages. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nanjing Medical Technology Development Fund.
Abstract (Originalsprache)
Uncontrolled proliferation is not the only factor driving tumor growth; the tumor microenvironment (TME) has a significant impact. Tissue homeostasis and pathogen removal depend on macrophages, which are important innate immune effector cells. Nevertheless, there is growing evidence that tumor-associated macrophages (TAMs) do not consistently suppress cancer and are functionally diverse. Specifically, M2-polarized TAMs (M2-TAMs) build up in multiple solid tumors, where they promote angiogenesis, metastasis, and immunosuppression, hastening the course of the disease. Here, we critically assess the clinical translatability of TAM-targeted treatment approaches, outline the molecular circuits underpinning M2-TAMs–tumor cell interaction, and extensively explore the phenotypic spectrum and functional diversity of macrophages in cancer. Our objective is to offer a theoretical foundation for upcoming immunotherapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.
- Department of Thoracic Surgery, Affili-ated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
- Pulmonary Nodule Diagnosis and Treatment Research Center, Nanjing Medical University, Nanjing, China.
- Department of Thoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
ORCID-Profile: Qiang Zhang, Feng Shao
Förderung
- Nanjing Medical Technology Development Fund
Zitieren
APA
Zhang, Q., Sun, Y., Zhuang, Y., Yao, M., Jiao, S., Wang, Q., Zhang, X., & Shao, F. (2026). A New Perspective in Tumor Therapy: Targeting M2-Type Tumor-Associated Macrophages. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261448345
Vancouver
Zhang Q, Sun Y, Zhuang Y, Yao M, Jiao S, Wang Q, et al. A New Perspective in Tumor Therapy: Targeting M2-Type Tumor-Associated Macrophages. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261448345
BibTeX
@article{Zhang2026,
author = {Zhang, Qiang and Sun, Yungang and Zhuang, Yu and Yao, Mengxu and Jiao, Siyang and Wang, Qi and Zhang, Xiaoying and Shao, Feng},
title = {A New Perspective in Tumor Therapy: Targeting M2-Type Tumor-Associated Macrophages},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261448345}
}
EUVIMED